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of the Enterobacterial ClyA Cytotoxin
utilizing the type I pathway (Koronakis et al., 1991, 2000).
In the type II pathway, also known as the general secre-
tion pathway, proteins are first translocated through the
inner membrane to be accumulated in the periplasm
and are then transported across the outer membrane
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by either of several distinct “terminal branches” of theand Bernt Eric Uhlin1
process (Pugsley, 1993; Sandkvist, 2001). The type III1Department of Molecular Biology
system functions both as a pathway for secretion acrossUmea˚ University
the bacterial membranes and for translocation of theS-901 87 Umea˚
secreted bacterial proteins across the plasma mem-Sweden
brane of eukaryotic host/target cells (Galan and Collmer,2 Microbiology and Tumour Biology Centre
1999; Hueck, 1998). The type IV system also usuallyKarolinska Institutet
translocates proteins in a single step from the cytoplasmS-171 77 Stockholm
to the intracellular compartment of a target cell (ChristieSweden
and Vogel, 2000). The type V pathway is utilized by so-3 Department of Bacteriology
called autotransporter proteins (Henderson et al., 2000).Faculty of Medical Sciences
Such proteins possess an N-terminal signal sequenceKyushu University
and utilize the Sec system for translocation across theFukuoka 812-8582
inner membrane, whereas they mediate their own trans-Japan
location across the outer membrane by forming a pore
structure. The Tat system allows (in a Sec-independent
way) translocation of folded proteins carrying redox co-Summary
factors across the inner membrane (Sargent et al., 1998).
All of the mentioned pathways include some accessoryThe ClyA protein is a pore-forming cytotoxin ex-
proteins that may be commonly utilized by separatepressed by Escherichia coli and some other entero-
pathways (e.g. signal sequence peptidase; the Sec ap-bacteria. It confers cytotoxic activity toward mamma-
paratus) or specifically assembled for the particularlian cells, but it has remained unknown how ClyA is
pathway.surface exposed and exported from bacterial cells.
Recently, it became evident that even derivatives ofOuter-membrane vesicles (OMVs) released from the
the common laboratory strain E. coli K-12 can expressbacteria were shown to contain ClyA protein. ClyA
a hemolytic/cytolytic phenotype. Activation of a geneformed oligomeric pore assemblies in the OMVs, and
denoted clyA (hlyE, sheA) results in expression of thethe cytotoxic activity toward mammalian cells was
ClyA (cytolysin A) protein (Uhlin and Mizunoe, 1994; Os-
considerably higher than that of ClyA protein purified
carsson et al., 1996, 1999; del Castillo et al., 1997; Green
from the bacterial periplasm. The redox status of ClyA
and Baldwin, 1997; Ludwig et al., 1999). Intact E. coli
correlated with its ability to form the oligomeric pore cells expressing ClyA show cytotoxic effects upon direct
assemblies. In bacterial cells with a defective periplas- contact with mammalian cells and ClyA appeared to be
mic disulphide oxidoreductase system, the ClyA pro- a contact-dependent activity (Oscarsson et al., 1999;
tein was phenotypically expressed in a constitutive Lai et al., 2000). Structural studies revealed that ClyA
manner. The results define a vesicle-mediated trans- represents a new type of bacterial cytotoxins with a
port mechanism in bacteria, and our findings show protein folding different from previously studied toxins
that the localization of proteins to OMVs directly may (Wallace et al., 2000). In association with lipid mem-
contribute to the activation and delivery of pathogenic branes, in vitro ClyA forms an oligomeric pore-like
effector proteins. assembly that was suggested to be the active pore-
forming cytotoxin complex. Earlier studies with overpro-
ducing strains suggested that ClyA could accumulate
Introduction in the periplasmic space (Ludwig et al., 1999; Oscarsson
et al., 1999). Results from recent studies with ClyA pro-
Several distinct types of secretion pathways for proteins tein fusions indicate that the protein has an intrinsic
that are important for the bacterial interaction with host ability to get translocated across the cytoplasmic mem-
environments have been identified in gram-negative brane, and this does not require the cytolytic activity per
bacteria. The type I, and type III pathways are one- se (del Castillo et al., 2001). However, the ClyA protein is
translocated without cleavage of any N-terminal signalstep mechanisms by which the secreted proteins cross
sequence, and it has remained unknown how it is sur-directly from the cytoplasm to the bacterial surface.
face exposed and released from the bacterial cells.For example, the cytolytic HlyA and Ehx hemolysins are
Gram-negative cell walls have a dynamic feature that
is not seen in gram-positive counterparts. Outer-mem-*Correspondence: sun.nyunt.wai@molbiol.umu.se
brane vesicles (OMVs) are constantly being discharged4 Present address: The Lawson Health Research Institute, St. Jo-
from the surface of the cell during bacterial growth (re-seph’s Health Care London, 268 Grosvenor Street, London, Ontario,
Canada N6A 4V2. viewed by Beveridge, 1999). OMVs include outer-mem-
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brane proteins, lipopolysaccharide (LPS), and phospho-
lipids and, as the vesicles are being released from the
surface, they entrap some of the underlying periplasm.
Previous studies showed that bacterial OMVs had fusion
activity to mammalian target cells. For example, Kaduru-
gamuwa and Beveridge (1998) reported that the vesicles
from Shigella flexneri loaded with antibiotic are capable
to deliver the antibiotic into the cytoplasm of Henle cells
after the internalization of the vesicles. The release of
such vesicles has been suggested to be associated with
the surface exposure of a protein toxin in E. coli (Wai
et al., 1995; Horstman and Kuehn, 2002). Fiocca et al.
(1999) observed that the vesicles released from Helico-
bacter pylori bind to epithelial cells in vitro, as well as
to the gastric mucosal surface in vivo. Thus, they sug-
gested that H. pylori vesicles may play a role in the
delivery of bacterial components to host gastric tissue.
Recently, Kato et al. (2002) observed that the OMVs
secreted by Actinobacillus actinomycetemcomitans are
enriched in leukotoxin, and they suggested that the for-
mation of vesicles occurs by a process that results in
the enrichment of leukotoxin.
Here, we present evidence that the ClyA cytotoxin is
exported from the bacterial cell in OMVs and that it is
adopting a cytolytically active, oligomeric conformation
in the vesicles. We suggest that the results define a
vesicle-mediated transport mechanism in bacteria that
is responsible for the activation and delivery of patho-
genic effector proteins.
Results
Surface Exposure of ClyA
The surface exposure of ClyA on different E. coli K-12 Figure 1. Immunofluorescence Microscopic Analysis of ClyA Ex-
pressionstrains was observed by immunofluorescence micros-
Bacterial cells grown overnight at 37C in LB were treated withcopy as shown in Figure 1. ClyA was detected on the
mouse monoclonal anti-ClyA antibodies and subsequently with rho-surface of most cells of MC1061/pYMZ80, which is the
damine-conjugated anti-mouse IgG. Bacterial strains used: (A) andderivative carrying a multicopy plasmid clone of the clyA
(B), MC1061/pYMZ80; (C) and (D), MWK11; (E) and (F), MC1061/structural gene (Figures 1A and 1B). In order to assess pUC18; (G) and (H), YMZ19. (A), (C), (E), and (G) show phase contrast
the surface expression and export of ClyA protein with- microscopy and (B), (D), (F), and (H) show fluorescence microscopy
out the overproduction obtained from the cloned clyA of the preparations in a pairwise manner.
gene, we made use of strain MWK11, a derivative in
which the chromosomal clyA locus contains a better
recognition site for the CRP-cAMP regulatory complex graphs of MWK11 and YMZ19 in Figures 2D and 2E show
representative examples of vesicles near the bacterialand thereby expresses phenotypically detectable levels
of ClyA (Westermark et al., 2000). ClyA was detected on cells. At higher magnification using EM, we observed
small ring-like structures with a central electron-densethe surface of the majority of MWK11 cells (Figures 1C
and 1D). There was very little immunofluorescence de- core in vesicles from the ClyA-expressing strains (Fig-
ures 2F and 2G). These structures were suspected totected in the case of the vector control strain (MC1061/
pUC18), but a small subpopulation of cells (1%) appar- represent ClyA pore assemblies since they resembled
what had earlier been found after addition of purifiedently expressed high enough levels to be seen in this
analysis (Figures 1E and 1F). The chromosomal clyA:kan ClyA protein to membrane vesicles or planar membrane
bilayers in vitro. Eventually such preparations result inknockout mutant was completely negative (Figures 1G
and 1H). Taken together, the immunofluorescence stud- formation of pore structures that can be observed by
EM (Wallace et al., 2000; Wai et al., 2003).ies showed that the ClyA protein evidently was exposed
on the surface of the bacterial cells.
To get more detailed information about the surface ClyA Accumulation in OMVs
To further analyze the relationship between ClyA andcharacteristics of cells expressing ClyA, we examined
the bacteria by electron microscopy (EM) and by atomic vesicles, we purified vesicles from cell-free culture su-
pernatants of ClyA-positive and -negative strains (seeforce microscopy (AFM). We then found that there were
small outer-membrane vesicles surrounding the bacte- Experimental Procedures). These preparations were en-
riched in vesicles with a diameter within the range 50–rial cells. The AFM images of MC1061/pYMZ80, MWK11,
and YMZ19 cells in Figures 2A–2C, and the EM migro- 200 nm. In the case of the ClyA-producing bacteria (e.g.,
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Figure 3. Electron Microscopy of Isolated OMVs from E. coli K-12
and from Pathogenic E. coli and Salmonella
(A) OMVs from strain MC1061/pYMZ80.
(B) OMVs from strain YMZ19.
(C) OMVs from the E. coli O111:H isolate CCUG29196; the insert
shows immunoblot analysis using anti-ClyA antibodies of a whole-
cell extract (lane 1) and of the OMV preparation (lane 2).
(D) OMVs from the S. typhi strain JON42 carrying the ClyA plasmid
pMWK21; the insert shows immunoblot analysis using anti-ClyA
antibodies of the OMVs from (D) in lane 1 and of OMVs from vector
control in lane 2. The bar in (A) represents 200 nm in length.
strain MWK11; Figures 2F and 2G), there appeared some
larger vesicles in which the structures resembling ClyA
pore assemblies were observed. That the observed
structures really represented ClyA protein was shown
by immunolocalization using anti-ClyA antibodies in the
immunogold labeling method. An intense deposition of
gold particles was detected on the vesicles obtained
from ClyA- producing bacteria, whereas there was no
labeling in case of the ClyA-negative strain (Figures 2H
and 2I). We concluded that the pore-like structures were
ClyA protein assemblies.
Vesicles from the strains producing ClyA were some-
what heterogenous in size, and the larger vesicle struc-
tures were more common in the case of strains overpro-
ducing the cytotoxin (e.g., MC1061/pYMZ80; Figure 3A).
In addition to the pore-like structures, side views of the
presumed pore assemblies could be seen as spikes
protruding from the margin (Figures 2G and 3A). There
were no such structures observed with the vesicles ob-
tained from the ClyA-negative strain, but they retained
their more uniform size and appearance (Figure 3B).
Analyses of the protein content of the vesicle prepara-
tions are shown in Figure 4. Vesicles from the strains
MC1061/pYMZ80 and MWK11 contained relatively largeFigure 2. ClyA in OMVs of E. coli Cells
amounts of ClyA protein. In fact, ClyA appeared to be(A–C) AFM images of vesicles surrounding cells of the E. coli strains:
the most abundant protein present as judged by theMC1061/pYMZ80 (A), MWK11 (B), and YMZ19 (C).
(D–E) Electron microscopy (EM) of bacterial cells and associated intensity of silver staining (Figure 4A). Immunoblot analy-
vesicles of strains: MWK11 (D) and YMZ19 (E).
(F) EM analysis of OMVs from strain MWK11. Arrowheads point at
two of the pore structures.
(G) Higher-resolution micrograph of a vesicle from strain MWK11 (H–I) EM analysis by immunogold-labeling of ClyA in OMVs from
showing typical ClyA pore assemblies appearing as ring-like struc- strains MWK11 (H) and YMZ19 (I). Arrowheads point at two of the
tures with a central electron-dense core (white arrow) and as spikes 10 nm gold particles. The bars shown at the lower right corners of
protruding from the margin of OMVs (black arrow). Figures 2F–2I represent a length of 200 nm.
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membrane protein marker we used the leader peptidase
protein detected with anti-Lep antibodies. The results
clearly confirmed that the OMVs were derived from the
outer membrane (Figure 4C). That OMVs also contained
other periplasmic proteins was evident from immunoblot
analysis of the plasmid-encoded -lactamase that was
detected in the case of strains MC1061/pYMZ80 and
YMZ19/pYMZ80 (Figure 4D).
The EM and AFM analyses suggested that there were
similar numbers of OMVs associated with cells of the
different bacterial strains (Figures 2A–2E and data not
shown). The outer-membrane porin proteins appeared
equally abundant in the different OMVs according to the
silver staining (Figure 4A). We concluded that there was
no obvious difference in the amount of OMVs obtained
from the different ClyA-positive and -negative deriva-
tives. On the basis of the relative amount of porin pro-
teins present in the preparations, we estimated that
OMVs represented about 1% of the total outer-membrane
material. We suggest that the surface expression of ClyA
involves export from the periplasm via such vesicles.
ClyA Cytotoxin in OMVs from Pathogenic E. coli
and Salmonella
Recently, the ClyA cytotoxin was found in pathogenic
E. coli and in Salmonella enterica serovars Typhi and
Paratyphi A (Oscarsson et al., 2002a; 2002b). We also
Figure 4. Accumulation of ClyA Protein in OMVs studied the localization of ClyA cytotoxin in such iso-
(A) Silver staining after SDS-PAGE analysis of total cell extracts lates. Immunoblot analysis of OMVs from the entero-
(lanes 1, 3, and 5) and of OMV preparations (lanes 2, 4, and 6).
hemorrhagic strain CCUG29196 (serotype O111:H)Strains: MC1061/pYMZ80 (lanes 1 and 2), MWK11 (lanes 3 and 4),
confirmed that they contained appreciable amounts ofand YMZ19 (lanes 5 and 6). The positions of molecular size markers
ClyA protein (Figure 3C insert, lane 2). Similarly, we could(kD) are shown along the left side. Bands representing proteins
(ClyA, OmpA, OmpF, and OmpW) identified by N-terminal amino isolate OMVs from the S. typhi strain JON42, which is
acid sequencing are indicated along the right side. The band marked a derivative of strain Ty21a where the clyA gene was
by an asterisk represents flagellin. abolished by an in-frame deletion. Vesicles from JON42
(B) Immunoblot analysis of the ClyA content in whole cells (WC) and
carrying a vector plasmid were quite uniform in sizein preparations of outer-membrane vesicles (OMVs), as in (A).
and shape, whereas the OMVs from JON42 carrying(C) Immunoblot analysis of two outer-membrane proteins (OmpA
the trans-complementing clyA plasmid pMWK21 wereand TolC) and one inner-membrane protein (Lep) in subcellular frac-
tions and OMVs from strain MWK11. Samples: whole-cell proteins more similar to the OMVs from E. coli cells expressing
(WC), cytosolic proteins (C), inner membrane proteins (I), periplasmic ClyA (Figure 3D and data not shown). Immunoblot analy-
proteins (P), outer-membrane proteins (O), and outer-membrane sis confirmed that there was ClyA protein present in
vesicles (OMV).
OMVs from the ClyA positive S. typhi (Figure 3D insert,(D) Immunoblot analysis of -lactamase in subcellular fractions (Ab-
lane 1). We conclude from these experiments that thebreviations: P, periplasmic proteins; C, cytosolic proteins; M, mem-
ClyA cytotoxin is exported via OMVs also in the case ofbrane proteins) of strain MC1061/pYMZ80 (lanes 1–3) and in OMVs
from MC1061/pYMZ80 (lane 4), YMZ19 (lane 5), and YMZ19/pYMZ80 natural isolates of these different enterobacteria.
(lane 6).
ClyA Cytolytic Activity Is Associated with OMVs
To determine hemolytic activity, we used a contact he-
molytic assay (see Experimental Procedures). We com-sis using anti-ClyA antibodies confirmed the presence
of the ClyA protein in both the whole-cell preparations pared the activity with that of purified ClyA protein ob-
tained from the periplasm of the bacteria. Both the OMVsand in vesicles (Figure 4B). Determination of the N-ter-
minal amino acid sequence of each of the major protein and the purified ClyA elicited a dose-dependent re-
sponse on the blood cells (Figure 5A). While the OMVsbands showed that in addition to ClyA protein present
in case of the ClyA-producing bacteria, bands detected contained a similar amount of ClyA protein, we noted
that there was a clear difference in lytic activity. Thein all of the preparations represented three outer-mem-
brane proteins: sequences obtained were unambigu- results suggested that ClyA in the OMVs had more than
8-fold higher activity than the purified ClyA.ously showing that the proteins were OmpA, OmpF, and
OmpW. The preparations also contained some flagella, To assay the cytotoxic effect on growing target cells,
we studied how cultured HeLa cells were affected byas evidenced by presence of the flagellin protein. Addi-
tional evidence that they were OMVs was obtained by preparations of OMVs or by the purified ClyA protein. A
considerable level of toxicity toward the HeLa cells wasimmunoblot analysis using anti-OmpA and anti-TolC an-
tibodies. We also compared the OMVs with different observed by microscopy as soon as 15 min after the start
of the treatment with ClyA contained in OMVs (Figure 5B,subcellular fractions of the bacteria. As a specific inner-
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icity were observed after about 60 min and it took more
than 3 hr before the majority of cells were affected. In
control experiments with OMVs from the ClyA defective
strain (YMZ19), there was no obvious cytotoxicity ob-
served during the 6 hr duration of the studies (data
not shown).
To quantify the ClyA cytotoxicity, we used an assay
determining the release of the cytoplasmic enzyme lac-
tate dehydrogenase (LDH) from the HeLa cells upon
treatment with either the purified ClyA or with the OMVs
from strains MWK11 and YMZ19. The results were con-
sistent with the observations described above, and only
the ClyA-containing OMVs caused clear cytotoxicity
during the initial 60–120 min (Figure 5C). A cytotoxic
response also to the purified ClyA appeared after pro-
longed treatment (e.g., 18 hr), as seen earlier with macro-
phages (Lai et al., 2000).
A more-sensitive method to monitor cellular re-
sponses such as cell lysis is to study whether toxin
exposure alters the ion homeostasis of target cells.
Thus, we used a ratiometric imaging system to monitor
the intracellular calcium concentration in primary epithe-
lial cells from rat. This approach allows a rapid detection
of cell lysis, within the minutes range, on a single-cell
level. Cells preloaded with the calcium-sensitive dye
Fura-2/AM were exposed to ClyA at 30 nM in an OMV
preparation from strain MC1061/pYMZ80. Approxi-
mately 10 min after addition, a sustained elevation of
intracellular calcium was observed (Figure 6A). Within
30 min, all cells in the cell cluster showed a sustained
elevation of the intracellular calcium concentration, and
several of the cells had lysed. Cell lysis was shown as
an abrupt drop in immunofluorescence (ratio  0) due
to leakage of the calcium-sensitive dye out of the cell,
and this occurred normally within 1 hr (data not shown).
The cytotoxic effect was indeed due to the effect of
ClyA, since OMVs from the clyA mutant strain YMZ19
had no effect on the intracellular calcium concentration
(Figure 6B), not even at amounts twice as high as when
ClyA-containing OMVs were used. As shown in Figure
6C, the purified ClyA (60 nM) was unable to introduce
any alterations of the cells calcium homeostasis during
the duration of the experiment. These results are in
keeping with the above-described hemolysis and cyto-Figure 5. Cytolytic and Cytotoxic Activity of ClyA in OMVs
toxicity assays. Taken together, the results demonstrate(A) Quantification of hemolytic activity of ClyA in OMVs and of ClyA
that the ClyA protein exposed by the vesicle prepara-purified from the bacterial periplasm as monitored by a contact
tions was presented in a considerably more cytolyticallyhemolytic assay (see Experimental Procedures).
(B) HeLa cell cytotoxicity of ClyA in OMVs (top) and in purified form and cytotoxically active form than when the protein
(bottom). Nonconfluent layers of HeLa cells were treated with 150 was purified from the periplasmic compartment of the
nM ClyA and examined at different time points in the microscope bacteria.
for signs of cytotoxicity as indicated below each frame (“,” no
cytotoxicity; “,” signs of cytotoxicity observed; “,” most cells
Monomeric ClyA in the Periplasm and Oligomeraffected). An immunoblot analysis of the ClyA preparations is shown
as an insert; lane 1, ClyA in OMVs; lane 2, purified ClyA. Formation in the OMVs
(C) Cytotoxicity as manifested by LDH release from HeLa cells after We conducted crosslinking experiments in order to as-
treatment with OMVs from strains MWK11 and YMZ19 or with puri- sess the occurrence of monomeric and oligomeric ClyA
fied ClyA protein as in (B). The plotted values are the mean from
protein in the periplasm and in the OMVs (Figure 7A).three separate experiments and bars show the standard error.
The ClyA protein isolated from the periplasmic fraction
was mainly in the monomeric form (Figure 7A, lanes
1–3). However, ClyA present in OMVs appeared in thetop). Cells with altered, more round morphology started
to appear, and there was detachment of cells from the form of larger (more than 220 KDa) oligomeric com-
plexes (Figure 7A, lanes 4–9) presumably representingsurface. However, in the case of pure protein, the toxic
effect on HeLa cells only appeared after longer treat- the octameric ClyA complexes suggested to be the ac-
tive form of pore assemblies (Wallace et al., 2000).ment (Figure 5B, bottom). The first clear signs of cytotox-
Cell
30
the OMVs, there were clear indications that AMS groups
were added to free thiols in the protein. It appeared that
the majority of ClyA was present in reduced form and
migration was altered even when lower AMS concentra-
tions and shorter incubations were tested (Figure 7B,
lanes 4–9).
It was conceivable that the observed difference in
oligomer formation could be due to a local concentration
effect since, presumably, the effective concentration of
the protein may be much higher in the OMVs relative to
the ClyA in solution. We estimated from the relative
yields of ClyA protein in the different preparations that
the concentration can be 10-fold higher in the OMVs as
compared with that of the periplasm. After concentrating
the ClyA obtained from the periplasmic compartment
by vacuum evaporation and thereby obtaining a 10-
fold more concentrated solution, we repeated the cross-
linking test. The test, which was performed with two
different, independently isolated preparations, did not
provide evidence for oligomer formation due to the
higher protein concentration, but the ClyA protein re-
mained as monomers (data not shown). The result does
not rule out that a local concentration effect might con-
tribute to higher bioactivity of ClyA in OMVs, but it did
not seem to be the main mechanism.
To test if the lack of formation of oligomers in the
case of ClyA from the periplasm depended on the redoxFigure 6. ClyA Cytotoxicity Monitored by Ratiometric Calcium Im-
aging status per se, we performed crosslinking analysis with
Intracellular calcium measurements in renal proximal tubule cells the reduced protein after DTT treatment. As shown in
after treatment with (A) a sample with 30 nM ClyA in vesicles pre- Figure 7C, the reducing treatment of the ClyA protein
pared from MC1061/pYMZ80, (B) a corresponding amount of vesi- resulted in formation of oligomers that efficiently were
cles from the ClyA-negative strain YMZ19, or (C) purified ClyA pro- detected both after short (10 min) and more prolonged
tein (60 nM). Arrows indicate addition of stimuli. Arbitrary units (au)
crosslinking, and it was evident that formation of suchrepresent ratio changes corresponding to changes in intracellular
complexes did not require higher concentration of ClyA.[Ca2]. One representative experiment is shown for each stimulus,
and measurements from five cells in each case were plotted. The oligomers appeared similar (more than 220 KDa) to
those detected with ClyA present in OMVs (compare
Figure 7A). Furthermore, we found that the oligomeriza-
tion of the DTT treated protein resulted in higher cytolyticThe monomeric ClyA in the periplasm was shown to
activity. It showed more than 16-fold higher hemolytichave an intramolecular disulphide bond formed between
activity than the untreated ClyA protein (data not shown).the cysteine residues at positions 87 and 285 in the
We conclude that the ClyA protein had a differentpolypeptide (Atkins et al., 2000). The presence of the
redox status when present in the OMVs in comparisondisulphide bond was suggested to prevent oligomeriza-
with the ClyA protein from the periplasm, and evidentlytion of ClyA. To directly assess the status of the cysteine
this difference correlated with the difference in forma-residues and their involvement in disulphide bond for-
tion of oligomers and active pore assemblies.mation, we carried out alkylation of free thiols using
the high molecular mass molecule AMS (4-acetamido-
4 maleimidystilbene-2-2-disulfonic acid) as described Dsb Pathway-Dependent Redox Regulation
of ClyA Activityin the Experimental Procedures. Samples of the ClyA
protein purified from periplasm and of the OMVs con- In the periplasm of E. coli there are two complementary
pathways that catalyze the formation of disulphidetaining ClyA were subjected to the AMS alkylation and
were subsequently analyzed by immunoblot analysis bonds (reviewed by Ritz and Beckwith, 2001). DsbA and
DsbB in the disulphide bond formation pathway addwith anti-ClyA antibodies (Figure 7B). The purified ClyA
protein was not susceptible to become AMS derivatized, new disulphide bonds to folding proteins. The DsbC and
DsbG proteins in the disulphide isomerization pathwayas judged by the fact that it was not altered in its gel-
electrophoretic migration even after treatment with a rearrange existing bonds between incorrectly paired
cysteines. Since our analysis of ClyA indicated that thehigh concentration of AMS (Figure 7B lanes 1–3). We
take this as evidence that the cysteine residues in ClyA pore-forming activity of the protein might be dependent
on the redox status, we tested if expression of ClyAwere engaged in disulphide bonding. In tests after prior
treatment of the protein with the reducing agent dithio- activity was affected in E. coli strains with deficiency in
the disulphide bond formation pathway using the strainstreitol (DTT), we found that thiols became available for
AMS derivatization (data not shown), and the results HK205 (wild-type), HK229 (dsbA::Kan mutant), and
HK227 (dsbB::Kan mutant). We then made the remark-were consistent with the notion that the majority of ClyA
in the periplasm is in oxidized form. In the case of ClyA in able observation that the dsb mutant derivatives ex-
Export-Dependent Activity of a Bacterial Cytotoxin
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pressed hemolysis on blood agar plates (Figure 7D).
There were clear zones of lysis around the bacterial
colonies of the mutant strains, whereas the wild-type
strain was negative. The level of expression of ClyA
protein in E. coli K-12 strains is normally not high enough
to cause such a recognizable phenotype on blood agar
(Oscarsson et al., 2002a). To check if the ClyA protein
level was altered, we carried out immunoblot analysis
of total bacterial cell extracts using anti-ClyA antibodies.
The ClyA protein levels in the dsb mutant bacteria were
not increased in comparison with the wild-type strain
(Figure 7E). The quantitative LDH release assay was
used to test cytotoxicity of the different bacterial strains
to HeLa cells. For comparison, we included the ClyA-
expressing strain MWK11 and the ClyA-deficient strain
YMZ19. The results from assays after treatment of HeLa
cells with the bacteria are summarized in Figure 7F. In
keeping with the hemolysis phenotypes, we found that
the dsb mutant strains displayed cytotoxicity, whereas
the wild-type strain did not.
meric and oligomeric ClyA forms in preparations from the periplasm
and from OMVs. ClyA purified from the periplasmic fraction of strain
MWK11: lane 1, no treatment; lane 2, 2.5 mM glutaraldehyde treat-
ment during 10 min; lane 3, 2.5 mM glutaraldehyde treatment during
30 min. ClyA in OMVs from strain MWK11: lanes 4 and 7, no treat-
ment; lanes 5 and 8, 2.5 mM glutaraldehyde treatment during 10
min; lanes 6 and 9, 2.5 mM glutaraldehyde during 30 min. Lanes
1–6 are showing samples in a 13% gel and lanes 7–9 are showing
samples in a 8% gel. Positions of molecular size standards are
shown along the sides.
(B) Analysis of redox status of the purified ClyA protein from the
periplasm and ClyA in OMVs. Alkylation of free thiols using the high-
molecular mass molecule AMS was carried out as described in the
Experimental Procedures. The samples were subsequently sub-
jected to SDS-PAGE and immunoblot analysis with anti-ClyA anti-
bodies, and the positions of oxidized (oxi, lower arrow) and reduced
(red, upper arrow) forms are indicated. Lanes 1–3: Purified ClyA
from periplasm treated with 45 mM AMS during 0, 30, and 60 min,
respectively. Lanes 4–6: ClyA in OMVs treated with 45 mM AMS
during 0, 30, and 60 min, respectively. Lanes 7–9: ClyA in OMVs
treated with 15 mM AMS during 0, 30, and 60 min, respectively.
(C) Oligomer formation by the ClyA preparation from the periplasm
after treatment with the reducing agent DTT. ClyA untreated (lanes
1, 3, and 5) or DTT treated (lanes 2, 4, and 6) for the indicated
amount of time was subjected to the cross-linking analysis with
glutaraldehyde (compare Figure 7A).
(D) Effect of dsb mutations on the phenotypic expression of ClyA.
The strains HK205, HK229, and HK227 which have wild-type,
dsbA::Kan, or dsbB::Kan loci, respectively, were grown on blood
agar plates at 37C.
(E) Immunoblot analysis of the ClyA protein levels in total cell ex-
tracts from the dsb (lane 1), dsbA::Kan (lane 2), and dsbB::Kan
(lane 3) strains grown as shown in (C).
(F) Cytotoxicity expressed by dsb mutant E. coli as monitored using
the LDH release assay with Hela cell cultures. Bacterial cells were
incubated together with HeLa cells (at a multiplicity of infection of
ten) during 150 min before determining the release of LDH (see
Experimental Procedures for details).
(G) Differential localization of the DsbA and ClyA proteins in the
periplasm and OMVs. Cell extracts of the dsb strain MWK11 and
a dsbA::Kan transductant (SNW200) were analyzed by immunoblot-
ting using both anti-DsbA antibodies and anti-ClyA antibodies.
Lanes 1 and 2 show whole-cell (WC) extracts of MWK11 and
SNW200, respectively. Lane 3 shows the OMV fraction of strain
MWK11. Lanes 4 and 5 show periplasmic (P) fractions of strain
Figure 7. Control of ClyA Redox Status and Oligomer Formation by MWK11 and SNW200, respectively.
the Dsb System (H) Summary of the DsbA-dependent redox status and the monomer
(A) Glutaraldehyde crosslinking and immunoblot analysis of mono- versus oligomer status of ClyA in the periplasm and in OMVs.
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Genetic analyses that included derivatives with an in- A possible reason for a change with respect to the
redox status of proteins in OMVs is suggested when weframe deletion of the clyA locus verified that the hemo-
lytic/cytolytic phenotype was due to the activity of ClyA. look at the proposed role and location of the different
Dsb proteins involved in disulphide bond formation inThe dsbA::Kan mutation was introduced by transduction
into strains M182 and MWK7, which are wild-type and the periplasm (reviewed by Ritz and Beckwith, 2001).
The periplasmic space in E. coli is favorable for disul-clyA derivatives, respectively. All dsbA::Kan transduc-
tants of M182 were showing the positive hemolytic phe- phide bond formation as it contains the thiol oxidant
DsbA protein and the disulphide bond isomerase DsbC.notype, whereas the MWK7 transductants did not. The
results confirmed that the activity of ClyA was depen- The DsbB protein is a cytoplasmic membrane protein
responsible for maintaining DsbA in an oxidized state.dent on the disulphide bond formation pathway in a
manner that was consistent with the redox status of Using immunoblot analysis, we found that little or no
DsbA protein was localized in the OMVs together withthe protein.
To assess if ClyA and DsbA were colocalized in both the ClyA cytotoxin while it was readily detected in the
periplasmic compartment (Figure 7G). The -lactamase,periplasm and OMVs, we assayed whole-cell extracts,
OMVs, and periplasmic extracts of the ClyA-producing which is another periplasmic protein, was clearly de-
tectable in both compartments, although the ratio ofstrain MWK11 in immunoblot analysis (Figure 7G, lanes
1, 3, and 4). A dsbA::Kan mutant transductant (SNW200) -lactamase between OMV and periplasm was lower
than that of ClyA (Figures 4D and 7G). Assuming thatof MWK11 was included as control (Figure 7G, lanes 2
and 5). The ClyA protein was detected together with some undetected amount of DsbA was localized in the
OMVs, the protein would no longer be in contact with thethe DsbA protein in whole-cell extracts and periplasmic
extracts. However, in the OMVs, there was no detectable DsbB protein and, consequently, the disulphide oxidase
activity of DsbA could be expected to be less efficient.DsbA protein (compare lanes 3 and 4 in Figure 7G). We
obtained the same result with two separate preparations We should emphasize that it is not ruled out that there
could be some costimulatory component(s) of ClyA ac-of OMVs from strain MWK11 (Figure 7G and data not
shown). While we do not exclude that a small amount tion in the membrane vesicles. However, the observed
difference in redox status and the findings with the dsbof DsbA might be localized to the OMVs, the results
clearly demonstrated that the ratio between DsbA and mutant bacteria suggested that the Dsb components
were important here. We do not have any evidence forClyA was very different in the periplasmic and OMV
compartments, and this difference was consistent with direct involvement of some disulphide reductase in the
OMVs, but it may be considered. In any case, by virtuethe redox status of ClyA.
of the separation from some of the Dsb components,
the oxidation of ClyA and other proteins would be ex-Discussion
pected to be less efficient in the OMV compartment.
Our data are consistent with such a model, and it wasThis work defines a vesicle-mediated transport mecha-
evident that the ClyA protein might thereby becomenism in bacteria that is responsible for the activation
more active in the formation of the oligomeric pore-and delivery of pathogenic effector proteins, seemingly
forming assemblies. While it remains to be elucidated,independent of the previously described type I–V secre-
our findings raise intriguing questions about the possi-tions systems. Our studies demonstrate that the ClyA
bility that there could be some mechanism of crudecytotoxic protein is found in the form of active oligomeric
sorting, in which some periplasmic proteins are moreassemblies in outer-membrane-derived vesicles re-
or less excluded from OMVs.leased from the bacterial cells during normal growth.
A different role for OMVs released by E. coli in connec-We conclude that the ClyA protein, which is present
tion with toxin secretion has been suggested in previousin monomeric form in the periplasm, is undergoing an
studies. Secretion of the heat labile toxin (LT) from entero-oligomerization and forms the active pore assemblies
toxigenic E. coli (ETEC) to the external environment wasin the OMVs and that this change into the active form
associated with release of OMVs (Wai et al. 1995; Horst-is dependent upon the altered redox status (Figure 7H).
man and Kuehn, 2000). Secretion of LT from E. coliWe may consider this assembly of ClyA oligomers in
occurs via the GSP, and recent studies suggested thatOMVs as a process, which exports ClyA in an active
the majority of LT subsequently associates with LPSform to the external environment.
on OMVs (Tauschek et al., 2002; Horstman and Kuehn,It is feasible that the OMVs containing ClyA were fus-
2002). The ClyA protein is not dependent on the GSPing with the target cells and that the cytotoxin thereby
secretion system as evidenced by tests with a gspFalso was more efficiently delivered to the target cell
knockout mutant, and none of the other known secretionmembranes. However, more importantly, the present
systems (types I–V) appear to be involved directly (ourfindings establish that both export and the formation of
unpublished data). It was proposed that LPS tethered LTcytotoxically active pore assemblies are facilitated by
to OMVs and that the interaction facilitated intoxicationthe release of OMVs. We conclude that our studies of
(Horstman and Kuehn, 2002). These studies also showedthe ClyA cytotoxin have revealed a bacterial export-
that the LT interaction with LPS neither attenuates nordependent activation pathway. Since the Dsb system is
enhances toxicity per se. In the case of the ClyA protein,important for many periplasmic bacterial proteins we
we suggest that it is incorporated in the OMVs as partmust consider the possibility that localization to OMVs
of the periplasm that is released from the cells by themay be of relevance for the action and function also in
vesicle formation. It should be emphasized that our find-other cases where the redox status of the protein can
be affected. ings with the ClyA cytotoxin thereby provided evidence
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ted onto PVDF membranes. The sequencing was performed on afor physiological relevance of prokaryotic vesicle for-
Procise 494 Sequencer (Applied Biosystems) with an on-line PTH-mation.
analyzer. A sufficient number of residues were determined to allow
unambiguous identification (100% identity; using the NCBI BLASTExperimental Procedures
database).
Bacterial Strains and Growth Conditions
Bacterial strains used were (1) E. coli K-12: strain MC1061 (Casada- Assay of Hemolytic Activity
ban and Cohen, 1980), strain M182 (Casadaban, 1976), the M182 Phenotypic test of hemolytic activity on blood agar plates and the
clyA derivative MWK7 (Westermark et al., unpublished construc- quantitative contact hemolytic assay were performed as previously
tion), the clyA::Kan strain YMZ19 (Oscarsson et al., 1996), the ClyA described (Oscarsson et al., 1999).
strain MWK11 (Westermark et al., 2000), the dsb strain HK205 and
the dsbA::Kan and dsbB::Kan mutants HK229 and HK227, respec-
Cytotoxicity Assays with HeLa Cellstively (Kadokura et al., 2000), and SNW200 (a dsbA::Kan mutant
HeLa cells were cultured in Ham’s F-10 medium supplemented withtransductant of MWK11, this work); (2) the E. coli O111:H isolate
10% fetal calf serum using standard procedures. Cells treated withCCUG29196 (Whittam et al., 1988); and (3) the Salmonella enterica
pure ClyA or OMVs were fixed in PBS containing 3% paraformalde-serovar Typhi derivative JON42 (Oscarsson et al., 2002b). The
hyde for 15 min at room temperature before the samples were ob-pYMZ80 clone was described earlier (Oscarsson et al., 1999). The
served using a Zeiss Standard WL phase-contrast microscope.Thebacterial strains were grown aerobically, with shaking, at 37C in
quantitative lactate dehydrogenase (LDH) release assay was per-Luria-Bertani (LB) broth or on agar. Blood agar plates contained 5%
formed using the CytoTox 96 nonradioactive cytotoxicity assay kit(v/v) horse erythrocytes. Antibiotics were added to LB broth or agar
(Promega). In tests with bacterial cells, the multiplicity of infectionat the following final concentrations: 50 g ml1 carbenicillin or 30
was ten, and bacterial growth was inhibited by addition of 15 g/g ml1 kanamycin.
ml chloramphenicol. At the onset of the incubation, the bacteria and
HeLa cells were centrifuged at 2800 rpm for 15 min.Immunofluoresence Microscopy
Using monoclonal anti-ClyA antibody and rhodamine-conjugated
anti-mouse IgG (Jackson Immunoresearch Laboratories, Inc.), we
Calcium Imagingperformed immunofluorescence labeling of bacterial cells as de-
The animal studies were approved by the Swedish Ethical Committe,scribed earlier (Xia et al., 2000).
Karolinska Institutet. Primary proximal tubule cells were prepared
from kidneys from 20-day-old female Sprague-Dawley rats and usedElectron Microscopy
in ratiometric calcium imaging experiments as previously describedProcedures for immunogold labeling and electron microscopy were
(Larsson et al., 1986; Uhle´n et al., 2000). Cells loaded with 2 Messentially as described earlier (Wai et al., 1998).
Fura-2 acetylmethyl ester (Fura-2/AM) (Molecular Probes) were ex-
posed to OMVs or purified ClyA.
Atomic Force Microscopy
Imaging was done on a Nanoscope IIIa Atomic Force Microscope
(Digital Instruments) using Tapping Mode. The final images were Protein Crosslinking
plane fitted in both axes and presented in a surface plot of the ClyA preparations from the periplasm or as OMVs were subjected
height mode. to the treatment with 2.5 mM glutaraldehyde during 10 or 30 min
as described (Chen et al., 1996).
Isolation of OMVs
OMVs were isolated from culture supernatants as previously de-
Determination of ClyA Redox Statusscribed with some modifications (Wai et al., 1995). After centrifuga-
Treatment of ClyA protein with the alkylating high molecular masstion at 5000 	 g for 15 min at 4C, the supernatants were filtered
molecule AMS (4-acetamido-4 maleimidystilbene-2-2-disulfonicthrough a 0.45 m vacuum filter. OMVs were then collected by
acid; Molecular Probes) was carried out essentially as describedcentrifugation at 150,000	 g for 3 hr at 4C in a 45 Ti rotor (Beckman
(Joly and Swartz, 1997). 15 mM or 45 mM AMS was added to proteinInstruments, Inc.). The pellets were suspended in 20 mM Tri-HCl
samples in 50 mM Tris-HCl (pH 8.0), 1% SDS-PAGE, and 1 mM(pH 8.0) and used as the OMVs’ preparation.
EDTA and incubation was done at 37C during 30 or 60 min. The ClyA
protein was examined by immunoblot analysis. The AMS-derivatizedCell Fractionation and Purification of ClyA Protein
ClyA migrated slightly slower in SDS-PAGE as expected since eachDifferent subcellular fractions were obtained using procedures de-
AMS conjugated moiety increases the molecular mass by 490 Dascribed recently (Oscarsson et al., 2002b; Wai et al., 2003). ClyA
(Joly and Swartz, 1997).protein from the periplasmic fraction was purified by fast-protein
liquid chromatography (FPLC) with a MonoQ ion exchange column
(Pharmacia) as described (Wai et al., 2003).
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